Artificial intelligence can use brain recordings from a single night in a sleep lab to predict a person's risk of developing ...
News-Medical.Net on MSN
MD Anderson and SOPHiA GENETICS join forces to accelerate data-driven cancer care
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient's own T-cells to target tumors.
Researchers at Palo Alto, Calif.,-based Stanford Medicine have developed an AI model capable of predicting an individual’s risk of developing more than 100 health conditions using sleep study data.
Recent trials highlight T-DXd's superior efficacy and manageable toxicity in treating high-risk HER2-positive breast cancer, reshaping treatment strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback